Aidoc vs Qure AI (2026)
Two imaging AI companies built for different settings. Aidoc runs aiOS, a platform that hosts its own cleared algorithms alongside partner algorithms for hospital imaging estates, with a January 2026 clearance (K252970) for triage of 11 acute findings on body CT built on its CARE foundation model. Qure sells chest X-ray, head CT, chest CT and musculoskeletal products in more than 105 countries by its own count, with tuberculosis screening products it says are WHO evaluated and care platforms for health programs. In the US its newest clearance, qXR-Detect (K251934, January 2026), is a concurrent reading aid for six categories of chest X-ray findings with a Predetermined Change Control Plan. A US health system running acute triage across CT looks at Aidoc. A program screening chest X-rays where radiologists are scarce, or a system that wants chest X-ray detection with a cleared update plan, looks at Qure.
- Acute triage across body CT from one foundation model: 11 findings cleared in January 2026, sold with three earlier ones as a 14 finding workflow.
- Performance published with its denominator: sensitivity of 94.0 to 99.3 percent and specificity of 95.7 to 99.3 percent across the 11 findings, on 280 cases per finding from six US sites.
- One platform for its own and partner algorithms, with continuous performance monitoring and care coordination built in.
- Chest X-ray detection with a cleared change plan: qXR-Detect's Predetermined Change Control Plan sets out how the model can be updated and how users are told.
- Tuberculosis screening evidence from independent studies in several countries and a 2025 systematic review.
- A stated privacy position: its cloud path receives only images stripped of identifiers, and on premise installation keeps processing on the customer's own servers.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Aidoc and Qure AI are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
Side by Side
Each record in one paragraph
Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached. Generated from this pair’s live capability grades, so it moves when a grade moves.
The AI Health Index awards Aidoc its top capability grade on FDA and Regulatory Status. Set against Qure AI, Aidoc grades higher on AI Liability and Recourse and EHR and Interoperability Depth. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, September 2026
The AI Health Index awards Qure AI its top capability grade on Model and Technology Transparency and FDA and Regulatory Status. Set against Aidoc, Qure AI grades higher on Model and Technology Transparency and HIPAA and BAA Posture. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, September 2026
Questions buyers ask
Should we choose Aidoc or Qure AI?
On the axes where the AI Health Index separates them, Aidoc grades higher on AI Liability and Recourse and EHR and Interoperability Depth, and Qure AI grades higher on Model and Technology Transparency and HIPAA and BAA Posture. Neither leads on the greater share of scored axes, so the decision turns on which constraint is binding rather than on an overall winner.
Where do Aidoc and Qure AI differ most?
The widest separation the AI Health Index records between Aidoc and Qure AI is on AI Liability and Recourse, where Aidoc grades B and Qure AI grades C. That axis sits in the Regulatory and Compliance group, so it should carry the most weight for a buyer whose binding constraint is where regulatory exposure sits and who carries it.
Where do Aidoc and Qure AI grade the same?
The AI Health Index grades Aidoc and Qure AI the same on several axes, including AI Centrality, Autonomy and Oversight Model and Model Supply Chain Disclosure. Neither holds an advantage the index can evidence on those axes, so they should not carry weight in a selection between these two.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Clinical Decision Support page.
Both records were reviewed on this site in September 2026. Qure markets sorting out unremarkable chest X-rays, citing a 99 percent negative predictive value from a service evaluation, and does not say who reads the studies set aside; that use is not part of its US clearances, so ask before switching it on.
Aidoc does not state business associate status or whether customer studies train its models. Qure's US summaries report sensitivity or area under the curve without the number of scans tested, so ask for the case counts. Prevalence matters too: the same sensitivity and specificity produce a very different false positive burden in a screening program than in an emergency department. Neither publishes pricing.